Hello everyone, I’m Quantified Simplicity, an amateur player focused on Hong Kong and US IPO research. I enjoy writing IPO analysis articles, and if my content helps with your IPO investments, please follow me.
Shineway Medical-B announced the lottery results today, and the situation doesn’t seem promising. Hopefully, the afternoon grey market trading will bring a miracle.
1. Shineway Medical-B Lottery Analysis
I. Lottery Results:
Shineway Medical-B (06609.HK)
Number of subscribers: 235,000 people
Category B applicants: 2,206 people
Oversubscription ratio: 333.14 times
Lottery success rate for one lot: 10%
Secure one lot by subscribing to 200 lots
Number of top bids: 73
Clawback ratio: 50%
Issue price: HKD 171 (upper limit)
Per lot: HKD 8,550
Tail allocation for Class A investors: 2 lots
Head allocation for Class B investors: 10 lots (value: HKD 85,000)
Top bid allocation: 75 lots (value: HKD 641,000)
II. Cornerstone situation: 10 cornerstone investors were introduced, accounting for 45.46.98% of the issuance. These cornerstone investors include Lake Bleu Prime (Blue Pool Capital), Boyu Capital Opportunities Master Fund (Boyu Capital), Octagon Investments, Aspex, Sage Partners, Superstring, The Valliance Fund, LYFE CAPITAL, 3W Fund, GHFFSP
...